GlassScriptPhysician profile
Ramesh Gopalaswamy
NPI 1437167129
$34,320.54
in general payments reported to CMS, 2019-2025
77 companies · $7,595 in 2025
The $7,595 reported for 2025 was more than what 88% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,276 · 2020: $2,190 · 2021: $3,039 · 2022: $4,267 · 2023: $5,566 · 2024: $9,387 · 2025: $7,595.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20K · Consulting Fee: $2,850 · Education: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19,584.82 |
| Consulting Fee | $2,850.00 |
| Education | $113.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $5,368.76 | 2019-2025 | Briviact, Rystiggo, Fintepla |
| Abbvie INC. | $2,587.52 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $2,372.16 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Alexion Pharmaceuticals, INC. | $1,214.72 | 2019-2025 | Ultomiris |
| Ani Pharmaceuticals, INC. | $1,200.60 | 2023-2025 | Purified Cortrophin Gel |
| Amgen INC. | $1,126.86 | 2019-2025 | Tepezza, Uplizna |
| Genzyme Corporation | $1,121.82 | 2019-2023 | |
| Argenx US, INC. | $1,041.03 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Pfizer INC. | $1,030.99 | 2023-2025 | |
| Emd Serono, INC. | $1,029.25 | 2019-2025 | Mavenclad, Mavenclad |
| Eisai INC. | $1,026.17 | 2019-2025 | |
| Catalyst Pharmaceuticals, INC. | $991.07 | 2019-2025 | Fycompa, Firdapse |
| Neurocrine Biosciences, INC. | $953.02 | 2020-2025 | Ingrezza, Ongentys |
| Lilly USA, LLC | $764.47 | 2019-2025 | Amyvid, Kisunla, Zepbound |
| Sunovion Pharmaceuticals INC. | $746.41 | 2019-2022 |
Show all 77 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $635.26 | 2021-2023 | Tepezza |
| Biogen, INC. | $631.43 | 2019-2025 | Leqembi, Skyclarys, Spinraza |
| Mallinckrodt Hospital Products INC. | $543.96 | 2020-2025 | Acthar |
| Jazz Pharmaceuticals INC. | $533.51 | 2020-2024 | |
| Otsuka America Pharmaceutical, INC. | $477.84 | 2023-2025 | Rexulti, Nuedexta |
| Novartis Pharmaceuticals Corporation | $472.00 | 2019-2025 | |
| Csl Behring | $469.60 | 2019-2024 | Hizentra |
| Sk Life Science, INC. | $453.23 | 2020-2025 | |
| Grifols USA, LLC | $409.15 | 2019-2025 | Gamunex-C, Xembify |
| Allergan, INC. | $362.78 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $333.48 | 2020-2023 | Ponvory |
| Janssen Biotech, INC. | $324.10 | 2025 | |
| Biohaven Pharmaceuticals, INC. | $317.21 | 2020-2021 | |
| Neurelis, INC. | $312.68 | 2020-2025 | Valtoco |
| Amneal Pharmaceuticals LLC | $281.08 | 2020-2025 | Crexont, Rytary, Ongentys |
| Nevro Corp. | $267.29 | 2022-2024 | Senza |
| Glaxosmithkline, LLC. | $250.00 | 2024-2025 | Nucala, Arexvy |
| Takeda Pharmaceuticals U.S.A., INC. | $248.27 | 2022-2025 | Hyqvia, Gammagard |
| Lundbeck LLC | $243.30 | 2024-2025 | Vyepti |
| Tanabe Pharma America, INC. | $234.13 | 2019-2024 | |
| Acorda Therapeutics, INC | $231.50 | 2019-2023 | Inbrija |
| Alnylam Pharmaceuticals INC. | $215.69 | 2022-2025 | Onpattro, Givlaari |
| Avion Pharmaceuticals | $193.42 | 2022-2023 | Dhivy |
| Astrazeneca Pharmaceuticals LP | $191.40 | 2021-2025 | Airsupra, Wainua |
| Biohaven Pharmaceutical Holding Company LTD. | $182.24 | 2022 | |
| Celgene Corporation | $180.70 | 2020-2025 | Zeposia |
| Merz Pharmaceuticals, LLC | $170.96 | 2022-2025 | Xeomin, Inbrija, Ampyra |
| Greenwich Biosciences, INC. | $170.49 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $167.58 | 2023-2024 | Ztlido |
| C2n Diagnostics, LLC | $164.54 | 2025 | Precivityad2 |
| Mdd US Operations, LLC | $148.38 | 2020-2025 | Apokyn |
| Galderma Laboratories, L.P. | $125.00 | 2025 | Nemluvio |
| Aucta Pharmaceuticals, INC. | $117.06 | 2025 | Motpoly Xr |
| Vanda Pharmaceuticals INC. | $108.05 | 2024-2025 | Ponvory |
| Adamas Pharmaceuticals, INC. | $102.05 | 2019-2021 | |
| Xeris Pharmaceuticals, INC. | $102.01 | 2022-2025 | Keveyis |
| E.R. Squibb & Sons, L.L.C. | $99.49 | 2022-2025 | Zeposia |
| Tg Therapeutics, INC. | $95.49 | 2025 | |
| Axsome Therapeutics, INC. | $87.60 | 2025 | Symbravo |
| Livanova USA, INC. | $87.00 | 2019-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Octapharma USA, INC. | $86.38 | 2023-2025 | Panzyga |
| Upsher-Smith Laboratories LLC | $86.35 | 2021-2023 | |
| Kyowa Kirin, INC. | $81.95 | 2024-2025 | Nourianz |
| Sumitomo Pharma America, INC. | $77.60 | 2023 | Aptiom |
| Genentech USA, INC. | $71.13 | 2022-2024 | Evrysdi |
| Acadia Pharmaceuticals INC | $64.44 | 2024 | Nuplazid |
| Abbott Laboratories | $63.87 | 2023-2025 | Infinity |
| Zyla Life Sciences, INC. | $58.66 | 2019 | |
| Ceribell, INC. | $52.08 | 2020 | |
| Supernus Pharmaceuticals, INC. | $49.51 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $48.46 | 2019 | |
| Akcea Therapeutics, INC. | $40.85 | 2019-2021 | |
| Globus Medical, INC. | $39.60 | 2025 | Senza |
| Microtransponder, INC. | $30.93 | 2025 | |
| Insightec,INC | $28.74 | 2023-2025 | Exablate |
| Life Molecular Imaging LTD | $25.79 | 2025 | Neuraceq |
| Cala Health, INC. | $22.09 | 2022 | |
| Impel Pharmaceuticals INC. | $18.47 | 2023 | Trudhesa |
| Vertical Pharmaceuticals, LLC | $15.71 | 2019 | |
| Boston Scientific Corporation | $15.54 | 2022 | |
| Aprecia Pharmaceuticals, LLC | $15.11 | 2020 | |
| Currax Pharmaceuticals LLC | $11.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramesh Gopalaswamy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.